NYSE:NEUE NeueHealth (NEUE) Stock Price, News & Analysis $6.78 -0.07 (-0.95%) Closing price 08/7/2025 03:58 PM EasternExtended Trading$6.78 0.00 (0.00%) As of 08/7/2025 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About NeueHealth Stock (NYSE:NEUE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NeueHealth alerts:Sign Up Key Stats Today's Range$6.73▼$6.8550-Day Range$6.75▼$6.9252-Week Range$3.79▼$7.66Volume4,910 shsAverage Volume5,284 shsMarket Capitalization$60.50 millionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingHold Company Overview NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida. Read More NeueHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreNEUE MarketRank™: NeueHealth scored higher than 41% of companies evaluated by MarketBeat, and ranked 805th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingNeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNeueHealth has received no research coverage in the past 90 days.Read more about NeueHealth's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeueHealth is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeueHealth is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.23% of the float of NeueHealth has been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeueHealth has recently decreased by 41.79%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeueHealth does not currently pay a dividend.Dividend GrowthNeueHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.23% of the float of NeueHealth has been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeueHealth has recently decreased by 41.79%, indicating that investor sentiment is improving significantly. News and Social Media3.3 / 5News Sentiment0.92 News SentimentNeueHealth has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for NeueHealth this week, compared to 1 article on an average week.Search Interest1 people have searched for NEUE on MarketBeat in the last 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,948.00 in company stock.Percentage Held by Insiders63.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about NeueHealth's insider trading history. Receive NEUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NEUE Stock News HeadlinesNeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript3 hours ago | seekingalpha.comTranscript : NeueHealth, Inc., Q2 2025 Earnings Call, Aug 07, 2025August 7 at 1:16 PM | marketscreener.comMCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities. | Brownstone Research (Ad)NeueHealth Reports Second Quarter 2025 ResultsAugust 7 at 7:50 AM | gurufocus.comNeueHealth Reports Second Quarter 2025 ResultsAugust 7 at 7:01 AM | businesswire.comNeueHealth (NEUE) Expected to Announce Earnings on ThursdayJuly 31, 2025 | americanbankingnews.comWalgreens health clinics coming to 2 Florida stores. Here's whereJuly 18, 2025 | msn.comNeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025July 17, 2025 | businesswire.comSee More Headlines NEUE Stock Analysis - Frequently Asked Questions How have NEUE shares performed this year? NeueHealth's stock was trading at $7.42 at the beginning of 2025. Since then, NEUE shares have decreased by 8.7% and is now trading at $6.7750. How were NeueHealth's earnings last quarter? NeueHealth, Inc. (NYSE:NEUE) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($1.80) earnings per share for the quarter, beating the consensus estimate of ($2.51) by $0.71. The company earned $215.79 million during the quarter, compared to analysts' expectations of $249.50 million. Read the conference call transcript. How do I buy shares of NeueHealth? Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeueHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT). Company Calendar Today8/07/2025Last Earnings8/07/2025Next Earnings (Estimated)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryInsurance Current SymbolNYSE:NEUE Previous SymbolNYSE:NEUE CIK1671284 Webwww.brighthealthgroup.com Phone612-238-1321FaxN/AEmployees1,252Year FoundedN/APrice Target and Rating Average Price Target for NeueHealth$7.00 High Price Target$7.00 Low Price Target$7.00 Potential Upside/Downside+3.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($22.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$134.68 million Net Margins-14.28% Pretax Margin-11.81% Return on EquityN/A Return on Assets-17.46% Debt Debt-to-Equity RatioN/A Current Ratio0.74 Quick Ratio0.74 Sales & Book Value Annual Sales$936.66 million Price / Sales0.06 Cash FlowN/A Price / Cash FlowN/A Book Value($163.57) per share Price / Book-0.04Miscellaneous Outstanding Shares8,930,000Free Float3,277,000Market Cap$60.50 million OptionableN/A Beta0.57 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:NEUE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.